NFSG
WST icon

Newbridge Financial Services Group’s West Pharmaceutical WST Stock Holding History

Newbridge Financial Services Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.14K Hold
17
– – ﹤0.01% 930
2026
Q1 		$4.29K Hold
17
– – ﹤0.01% 934
2025
Q4 		$4.7K Hold
17
– – ﹤0.01% 908
2025
Q3 		$4.48K Sell
17
-28
-62% -$6.8K ﹤0.01% 1037
2025
Q2 		$9.86K Sell
45
-450
-91% -$96.2K ﹤0.01% 891
2025
Q1 		$111K Buy
495
+450
+1,000% +$124K 0.03% 252
2024
Q4 		$14.7K Buy
+45
New +$14.2K ﹤0.01% 668
2024
Q3 		– Sell
-45
Closed -$14.8K – 1121
2024
Q2 		$14.8K Buy
45
+17
+61% +$6.01K 0.01% 632
2024
Q1 		$11.1K Hold
28
– – ﹤0.01% 743
2023
Q4 		$9.86K Hold
28
– – ﹤0.01% 739
2023
Q3 		$10.5K Hold
28
– – 0.01% 810
2023
Q2 		$10.7K Hold
28
– – 0.01% 873
2023
Q1 		$9.7K Buy
+28
New +$8.18K 0.01% 919
2021
Q3 		– Sell
-12
Closed -$4K – 1628
2021
Q2 		$4K Hold
12
– – ﹤0.01% 1184
2021
Q1 		$3K Hold
12
– – ﹤0.01% 1137
2020
Q4 		$3K Sell
12
-36
-75% -$10.1K ﹤0.01% 938
2020
Q3 		$13K Buy
+48
New +$12.7K 0.01% 619

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Newbridge Financial Services Group's WST Position: Q2 2026 in Review

Newbridge Financial Services Group held its West Pharmaceutical (WST) position steady in Q2 2026 at 17 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #930.

Newbridge Financial Services Group first reported a position in WST in Q3 2020 and has held it in 17 quarters since. The position peaked at $111K in Q1 2025. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Newbridge Financial Services Group held 17 shares of West Pharmaceutical worth $6.14K as of Q2 2026.
  • Newbridge Financial Services Group left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #930 holding.
  • Newbridge Financial Services Group first reported a position in West Pharmaceutical in Q3 2020 and has held it in 17 quarters since.
  • Newbridge Financial Services Group's West Pharmaceutical position peaked at $111K in Q1 2025.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.